Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Sevre-Long 30 mg, Kapseln retard | | 53952 | | 01 | | Sevre-Long 30 mg | | Kapseln retard | | N02AA01 | | Morphin | | 30.01.1997 | | |
| Composition | morphini sulfas pentahydricus 30 mg corresp. morphinum 22.56 mg, oleum vegetabile hydrogenatum, macrogolum 6000, talcum, magnesii stearas, Kapselhülle: E 132, E 171, natrii laurilsulfas corresp. natrium 0.006 mg, gelatina, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula. | Packungsbestandteile | | Capsules retard | | | Principe actif | Concentr. |
---|
Morphine Sulfate Pentahydrate | 30 mg correspond Morphine 22.56 mg |
| BAG: Principe actif | Concentr. |
---|
Morphini Sulfas Pentahydricus (2:1) | 30 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Nigrum) | | | E 132 | | Kapselhülle | E 171 | | color. | E 172 | | color. | Gelatina | | | Lacca | | Drucktinte | Macrogol | 6000 | | Magnesii Stearas | | | Natrii Laurilsulfas | | | Oleum Vegetabile Hydrogenatum | | | Pro Capsula | | | Propylenglycol | | | Talcum | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
011 | 30 Gélule(s) | 20.28 | 38.45 | A+ | LS | Oui |
|
|